Brief: Isofol: Clinical Use Patent In Europe For Drug Candidate Arfolitixorin Will Be Approved

Isofol Medical AB (publ)

22/03/2021 10:01

March 22 (Reuters) - Isofol Medical AB (publ)  ISOFOL.ST :
    * ISOFOL RECEIVES NOTICE THAT CLINICAL USE PATENT IN EUROPE
FOR
DRUG CANDIDATE ARFOLITIXORIN WILL BE APPROVED
    * PATENT COVERS A DOSE REGIMEN FOR TREATING SOLID TUMORS,
SUCH AS
COLORECTAL, STOMACH, BREAST AND LIVER CANCER AND EXPIRES IN 2038

Source text for Eikon:  ID:nWkr4fls4q 
Further company coverage:  ISOFOL.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;  +48 587696600;))